iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Mankind Pharma Ltd Option Chain

Add as a Preferred Source on Google
1,998.5
(-0.14%)
Apr 2, 2026|05:30:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,600₹4.2 78.72%1,80060%
--1,640₹7 81.81%9000%
--1,680₹10.95 0%2250%
--1,740₹8.9 0%9000%
--1,780₹15.9 -25%2,70020%
--1,800₹18.7 11.97%15,750180%
--1,820₹27.25 0%4,7250%
--1,840₹24.45 19.26%5,1750%
--1,860₹26.1 -0.38%9000%
1,5750%₹154.65 -0.22%1,880₹28.8 -1.03%10,5750%
1,3500%₹129.85 0%1,900₹39 14.2%30,375-33.82%
00%₹88.95 0%1,920₹47.85 19.62%4,0505.88%
2,250900%₹111.25 71.15%1,940₹51.25 9.62%12,8259.61%
4,050800%₹98.45 -0.9%1,960₹59.5 5.3%18,6756.41%
8,100414.28%₹90.5 -13.8%1,980₹76.75 24.69%2,250150%
75,3756.68%₹76.5 0.32%2,000₹78.3 8.07%35,550-0.62%
4,275-9.52%₹65 -2.4%2,020₹60.35 0%1,8000%
42,97513.01%₹58.8 2.34%2,040₹92.85 2.59%13,950-6.06%
1,8000%₹50.35 1.82%2,060₹78.75 0%1,1250%
1,125-37.5%₹43.75 3.55%2,080--
76,950-17.78%₹35.35 -2.21%2,100₹129.8 4.67%29,0250%
5,40020%₹32.95 7.5%2,120₹110.15 0%2250%
2,4750%₹23.1 -5.32%2,140₹130 0%6750%
3,1500%₹20 0%2,160--
1,12566.66%₹18.75 4.45%2,180--
48,37514.97%₹15.95 3.57%2,200₹260 18.64%6,0753.84%
225-50%₹9.65 -5.85%2,240--
1,575-36.36%₹7.4 -18.68%2,260₹308.7 0%2250%
29,7009.09%₹6.5 4.83%2,300₹259 0%1,3500%
2,4750%₹3.75 0%2,360--
--2,400₹393 0%3,6000%
--2,420₹410 0%2250%
4,0500%₹3.8 0%2,440₹490 0%2250%
4500%₹6.8 0%2,460₹249.75 0%2,2500%
5,4000%₹3.85 0%2,480₹540 0%4500%
5,6250%₹1.45 -12.12%2,500₹480 0%1,5750%
00%₹5 0%2,540--
--2,600₹655 0%6750%

Mankind Pharma: Related NEWS

Mankind Pharma Q1 Updates: Net profit down ~18%

The company also informed that its diluted earnings per share (EPS) slipped by 20.10% on a yearly basis to ₹10.60.

1 Aug 2025|01:41 PM
Read More
Top Stocks for Today - 01st August 2025

Here are some of the stocks that may see significant price movement today: Coal India, Mankind Pharma, Swiggy, etc.

1 Aug 2025|08:58 AM
Read More
Mankind Pharma posts mixed performance in Q4; stock slips ~4%

The business said that it logged a 10.70% year-on-year decline in its consolidated net profit at ₹420.80 Crore for Q4FY25.

22 May 2025|12:15 PM
Read More
Top Stocks for Today - 22nd May 2025

Here are some of the stocks that may see significant price movement today: NBCC, IndusInd Bank, Hindustan Zinc, etc.

22 May 2025|06:38 AM
Read More
Mankind Pharma Faces ₹183.11 Crore Tax Demand

The cumulative demand, including interest charges, is ₹183.11 crore.

30 Mar 2025|04:34 PM
Read More
Mankind Pharma Merges Three Subsidiaries

The merger took effect on March 29, 2025, after all necessary regulatory approvals were obtained.

30 Mar 2025|01:33 PM
Read More
Mankind Pharma Faces ₹111.68 Crore Tax Demand, Plans to Appeal

The tax adjustments pertain to Section 80IC/80IE, which involves deductions for businesses in special economic zones, and a disallowance of certain expenditures under Section 37(1) of the Act.

28 Feb 2025|11:13 PM
Read More
Top Stocks for Today - 24th January 2025

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

24 Jan 2025|07:50 AM
Read More
Mankind Pharma Q3 Profit Falls 16%, Revenue Jumps 24%

The company reported a good growth in EBITDA of 36.8% to ₹830 crore in the quarter against ₹606.5 crore in Q3 FY24.

23 Jan 2025|11:57 PM
Read More
Mankind Pharma Secures ₹5,000 Crore NCDs by Pledging 56.31% Stake in BSV

The NCDs issued are categorized, rated, secured, redeemable, and transferable, distributed across three series.

8 Jan 2025|04:01 PM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.